**Core Concept**
Pheochromocytoma and thyroid carcinoma are both rare endocrine neoplasms. The association between these two conditions is often seen in the context of multiple endocrine neoplasia (MEN) syndromes, particularly MEN 2A and MEN 2B. These syndromes are characterized by the occurrence of medullary thyroid carcinoma (MTC), pheochromocytoma, and other endocrine tumors.

**Why the Correct Answer is Right**
Medullary thyroid carcinoma is a neuroendocrine tumor that originates from the parafollicular cells (C cells) of the thyroid gland. In patients with MEN 2A or MEN 2B, there is a high risk of developing MTC, which is often associated with pheochromocytoma. The coexistence of these two conditions in this patient is suggestive of a MEN syndrome, making MTC the most likely diagnosis for her thyroid carcinoma.

**Why Each Wrong Option is Incorrect**
**Option A:** Papillary thyroid carcinoma is the most common type of thyroid cancer, but it is not typically associated with MEN syndromes or pheochromocytoma.
**Option B:** Follicular thyroid carcinoma is another type of thyroid cancer, but it is not specifically linked to MEN syndromes or pheochromocytoma.
**Option C:** Anaplastic thyroid carcinoma is a rare and aggressive type of thyroid cancer, but it is not typically associated with MEN syndromes or pheochromocytoma.

**Clinical Pearl / High-Yield Fact**
The association between medullary thyroid carcinoma and pheochromocytoma is a classic exam trap. When encountering a patient with both conditions, consider the possibility of a MEN syndrome, especially MEN 2A or MEN 2B.

**Correct Answer:** C. Medullary thyroid carcinoma.